Financial analysis of cardiovascular wellness program provided to self-insured company from pharmaceutical care provider's perspective.
OBJECTIVE
To perform a retrospective financial analysis on the implementation of a self-insured company's wellness program from the pharmaceutical care provider's perspective and conduct sensitivity analyses to estimate costs versus revenues for pharmacies without resident pharmacists, program implementation for a second employer, the second year of the program, and a range of pharmacist wages.


METHODS
Cost-benefit and sensitivity analyses.


METHODS
Self-insured employer with headquarters in Canton, N.C.


METHODS
36 employees at facility in Clinton, Iowa.


METHODS
Pharmacist-provided cardiovascular wellness program.


METHODS
Costs and revenues collected from pharmacy records, including pharmacy purchasing records, billing records, and pharmacists' time estimates.


METHODS
All costs and revenues were calculated for the development and first year of the intervention program. Costs included initial and follow-up screening supplies, office supplies, screening/group presentation time, service provision time, documentation/preparation time, travel expenses, claims submission time, and administrative fees. Revenues included initial screening revenues, follow-up screening revenues, group session revenues, and Heart Smart program revenues.


RESULTS
For the development and first year of Heart Smart, net benefit to the pharmacy (revenues minus costs) amounted to dollars 2,413. All sensitivity analyses showed a net benefit. For pharmacies without a resident pharmacist, the net benefit was dollars 106; for Heart Smart in a second employer, the net benefit was dollars 6,024; for the second year, the projected net benefit was dollars 6,844; factoring in a lower pharmacist salary, the net benefit was dollars 2,905; and for a higher pharmacist salary, the net benefit was dollars 1,265.


CONCLUSIONS
For the development and first year of Heart Smart, the revenues of the wellness program in a self-insured company outweighed the costs.
Wilson
Justin B
JB
ValuMed Pharmacy, Midwest City, Okla, USA. justin.wilson@cox.net
Osterhaus
Matt C
MC
Farris
Karen B
KB
Doucette
William R
WR
Currie
Jay D
JD
Bullock
Tammy
T
Kumbera
Patty
P
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003365:Costs and Cost Analysis; D003920:Diabetes Mellitus / Q000517:prevention & control / Q000628:therapy; D006282:Health Personnel / Q000191:economics* / Q000458:organization & administration*; D006293:Health Promotion / Q000191:economics*; D007348:Insurance, Health; D010593:Pharmaceutical Services / Q000191:economics* / Q000458:organization & administration*